| Literature DB >> 27065956 |
Zongwang Ma1, Niels Geudens2, Nam P Kieu1, Davy Sinnaeve2, Marc Ongena3, José C Martins2, Monica Höfte1.
Abstract
Orfamide-type cyclic lipopeptides (CLPs) are biosurfactants produced by Pseudomonas and involved in lysis of oomycete zoospores, biocontrol of Rhizoctonia and insecticidal activity against aphids. In this study, we compared the biosynthesis, structural diversity, in vitro and in planta activities of orfamides produced by rhizosphere-derived Pseudomonas protegens and related Pseudomonas species. Genetic characterization together with chemical identification revealed that the main orfamide compound produced by the P. protegens group is orfamide A, while the related strains Pseudomonas sp. CMR5c and CMR12a produce orfamide B. Comparison of orfamide fingerprints led to the discovery of two new orfamide homologs (orfamide F and orfamide G) in Pseudomonas sp. CMR5c. The structures of these two CLPs were determined by nuclear magnetic resonance (NMR) and mass spectrometry (MS) analysis. Mutagenesis and complementation showed that orfamides determine the swarming motility of parental Pseudomonas sp. strain CMR5c and their production was regulated by luxR type regulators. Orfamide A and orfamide B differ only in the identity of a single amino acid, while orfamide B and orfamide G share the same amino acid sequence but differ in length of the fatty acid part. The biological activities of orfamide A, orfamide B, and orfamide G were compared in further bioassays. The three compounds were equally active against Magnaporthe oryzae on rice, against Rhizoctonia solani AG 4-HGI in in vitro assays, and caused zoospore lysis of Phytophthora and Pythium. Furthermore, we could show that orfamides decrease blast severity in rice plants by blocking appressorium formation in M. oryzae. Taken all together, our study shows that orfamides produced by P. protegens and related species have potential in biological control of a broad spectrum of fungal plant pathogens.Entities:
Keywords: Magnaporthe oryzae; P. protegens CHA0 and Pf-5; biocontrol; fluorescent pseudomonads; nonribosomal peptide synthase; orfamides
Year: 2016 PMID: 27065956 PMCID: PMC4811929 DOI: 10.3389/fmicb.2016.00382
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Strains, reference sequences, and plasmids used in this study.
| Orfamide+, derived from rhizosphere of tobacco, Switzerland | Stutz et al., | |
| Orfamide+, derived from rhizosphere of cotton, Texas, USA | Howell and Stipanovic, | |
| CMR12a | Orfamide+, sessilin+, wild type derived from rhizosphere of red cocoyam, Cameroon | Perneel et al., |
| CMR12a-Clp1 | Orfamide+, sessilin−; mutant with insertion in sessilin (CLP1) biosynthesis genes, GmR | D'aes et al., |
| CMR5c | Orfamide+, wild type derived from rhizosphere of red cocoyam, Cameroon | Perneel et al., |
| CMR5cΔ | Orfamide−, mutant with deletion in | This study |
| CMR5cΔ | Orfamide−, mutant with deletion in | This study |
| CMR5cΔ | Orfamide−, mutant with deletion in | This study |
| Orfamide+, derived from rhizosphere of shepherd's purse, Japan | Takeuchi et al., | |
| PH1b | Derived from the phytotelma of a carnivorous plant, Malaysia | NCBI database |
| CMAA1215 | Derived from Brazilian mangroves, Brazil | Vasconcellos et al., |
| Wayne1R | Biological control strain derived from rhizosphere of corn, Wayne, Pennsylvania, USA | Rong et al., |
| Yeast strain for | Invitrogen | |
| Donor strain for conjugation; DAP− | Saltikov and Newman, | |
| PMQ30 | Gene replacement vector for | Shanks et al., |
| PMQ30-Δ | Vector for site specific mutagenesis of orfamide biosynthesis genes | This study |
| PMQ30-Δ | Vector for site specific mutagenesis of | This study |
| PMQ30-Δ | Vector for site specific mutagenesis of | This study |
| Causal agent of rice blast disease | Thuan et al., | |
| Causal agent of root rot disease on bean | Nerey et al., | |
| Oomycete pathogen causing white tip disease on leek | Bertier et al., | |
| Oomycete pathogen causing root rot on cucumber | Lab stock | |
Gm.
Figure 1. All orfamide-synthases contain three large structural genes, ofaA, ofaB, and ofaC; these structural genes synthesize 10 modules for amino acids biosynthesis and two TE domains for peptide release, each module contained three domains, A, condensation (C), and thiolation (T) domains. The detailed interpretation of orfamide-synthases and flanking regions of these strains is shown in Table 2. Only partial gene sequences of orfamide synthases of Pseudomonas sp. CMAA1215 could be retrieved from the GenBank database. Scale bar is 2 kb.
Putative orfamide-synthases and flanking region identified from .
| 1a | GCN5-related N-acetyltransferase | [100%] | [75%] | [100%] | |||||
| ALG76232.1 | AFH75326.1 | ERO60965.1 | |||||||
| 1b | RND efflux system, outer membrane lipoprotein | 100% | 99% | 99% | 99% | 87% | |||
| AGL83955.1 | BAO61507.1 | AAY91416.1 | WP_019094693.1 | WP_025130134.1 | |||||
| 2 | LuxR family transcriptional regulator | 100% | 99% | 100% | 99% | 80% [100%] | 78% [82%] | 80% [100%] | 88% [80%] |
| AGL83956.1 | BAO61508.1 | AAY91417.1 | WP_011060444.1 | ALG76233.1 | AFH75327.1 | ERO60966.1 | WP_025130133.1 | ||
| Nonribosomal peptide synthase | 100% | 99% | 99% | 99% | 80% [100%] | 79% [84%] | 80% ERO60967.1 | 83% [80%] | |
| AGL83957.1 | BAO61509.1 | AAY91419.3 | WP_019094694.1 | ALG76234.1 | AFH75328.1 | +78% ERO60968.1 | WP_025130132.1 | ||
| +87% ERO60969.1 | |||||||||
| Nonribosomal peptide synthase | 100% | 99% | 99% | 99% | 81% [100%] | 82% [89%] | 82% [99%] | 85% [80%] | |
| AGL83958.1 | BAO61510.1 | AAY91420.2 | WP_037007783.1 | ALG76235.1 | AFH75329.1 | ERO60970.1 | WP_025130131.1 | ||
| Nonribosomal peptide synthase | 100% | 100% | 99% | 98% | 82% [100%] | 82% [88%] | 80% ERO60971.1 | 86% [82%] | |
| AGL83959.1 | BAO61511.1 | AAY91421.3 | WP_019095728.1 | ALG76236.1 | AFH75330.1 | +ERO60972.1 | WP_025130130.1 | ||
| 3 | Macrolide efflux protein MacA | 100% | 99% | 99% | 99% | 93% [100%] | 92% [97%] | 93% [100%] | 98% [93%] |
| AGL83960.1 | BAO61512.1 | AAY91422.1 | WP_011060449.1 | ALG76237.1 | AFH75331.1 | ERO60973.1 | WP_025130129.1 | ||
| 4 | Macrolide efflux protein MacB | 100% | 99% | 99% | 99% | 93% [100%] | 91% [97%] | 96% [95%] | 97% [93%] |
| AGL83961.1 | BAO61513.1 | AAY91423.1 | WP_019095727.1 | ALG76238.1 | AFH75332.1 | ERO60957.1 | WP_025130128.1 | ||
| 5 | LuxR family transcriptional regulator | 100% | 99% | 99% | 99% | 78% [100%] | 74% [81%] | 78% [100%] | 78% [77%] |
| AGL83962.1 | BAO61514.1 | AAY91424.1 | WP_019095116.1 | ALG76239.1 | AFH75333.1 | ERO60958.1 | WP_025130127.1 | ||
| 6 | Flagellar basal body rod modification protein FlgD | [100%] | 99% | ||||||
| ALG76240.1 | ERO60959.1 | ||||||||
| 7 | Flagellar hook protein FlgE | [100%] | 99% | ||||||
| ALG76241.1 | ERO60960.1 | ||||||||
| 8 | Putative gnat family acetyltransferase | 100% | 100% | ||||||
| AGL83963.1 | BAO61515.1 | ||||||||
| 9 | Family 2 glycosyl transferase | 100% | 100% | ||||||
| AGL83964.1 | BAO61516.1 | ||||||||
| 10 | Hypothetical protein | AGL83965.1 | |||||||
| 11 | Hypothetical protein | WP_029978544.1 | |||||||
| 12 | Glyoxalase family protein | 100% | 100% | 100% | 99% | 82% [100%] | 79% [90%] | 82% [100%] | 91% [80%] |
| AGL83966.1 | BAO61517.1 | AAY91425.1 | WP_019095115.1 | ALG76242.1 | AFH75334.1 | ERO60961.1 | WP_025130125.1 | ||
| 13 | Heme transporter CcmD, radical SAM domain-containing protein | 100% | 99% | 99% | 99% | 93% [100%] | 92% [95%] | 93% [99%] | 97% [93%] |
| AGL83967.1 | BAO61518.1 | AAY91426.1 | WP_026020220.1 | ALG76243.1 | AFH75335.1 | ERO60962.1 | WP_025130124.1 | ||
The identity level of amino acids was compared by BLASTp search. The first BLASTp similarity comparison is based on protein sequence of P. protegens CHA0. The second BLASTp similarity comparison is based on Pseudomonas sp. CMR5c and the level of similarity is shown in brackets.
Partial NRPS sequences were retrieved from Pseudomonas sp. CMAA1215 in GenBank database.
Figure 2Molecular phylogenetic (Maximum Likelihood method with 500 of Bootstrap replications) analysis of A domains of orfamide synthases extracted from . The amino acids were predicted based on comparison of those reported orfamide-synthases in Pseudomonas sp. CMR12a and P. protegens Pf-5. A phylogeny tree was constructed based on rpoD and gyrB genes of orfamide-producing and related Pseudomonas species (B). The tree was constructed with MEGA5 (Maximum Likelihood method with 1000 Bootstrap replications).
Figure 3UPLC-MS analysis of crude extracts from selected . Samples of Pseudomonas sp. CMR12a were prepared from cells on soft agar plate since orfamide secretion in this strain is hampered by the presence of sessilin (D'aes et al., 2014). Samples of other Pseudomonas strains were prepared from supernatant of overnight liquid KB cultures.
Structure of orfamide derivatives isolated and characterized from .
| Orfamide A | C14:0-OH (3) | L-Leu | D-Glu | D-aThr | D-Ile | L-Leu | D-Ser | L-Leu | L-Leu | D-Ser | L-Val | CHA0, Pf-5 |
| Orfamide B | C14:0-OH (3) | L-Leu | D-Glu | D-aThr | D-Val | L-Leu | D-Ser | L-Leu | L-Leu | D-Ser | L-Val | CMR12a, CMR5c, CHA0, Pf-5 |
| Orfamide C | C12:0-OH (3) | L-Leu | D-Glu | D-aThr | D-Ile | L-Leu | D-Ser | L-Leu | L-Leu | D-Ser | L-Val | CHA0, Pf-5 |
| Orfamide D | C12:0-OH (3) | L-Leu | D-Glu | D-aThr | D-Val | L-Leu | D-Ser | L-Leu | L-Leu | D-Ser | L-Val | CMR12a, CMR5c |
| Orfamide E | C14:1-OH (3) | L-Leu | D-Glu | D-aThr | D-Val | L-Leu | D-Ser | L-Leu | L-Leu | D-Ser | L-Val | CMR12a, CMR5c |
| Orfamide F | C16:1-OH (3) | L-Leu | D-Glu | D-aThr | D-Val | L-Leu | D-Ser | L-Leu | L-Leu | D-Ser | L-Val | CMR5c |
| Orfamide G | C16:0-OH (3) | L-Leu | D-Glu | D-aThr | D-Val | L-Leu | D-Ser | L-Leu | L-Leu | D-Ser | L-Val | CMR12a, CMR5c, CHA0, Pf-5 |
The new orfamides F and G were isolated and characterized from Pseudomonas sp. CMR5c. All orfamides from Pseudomonas strains share an unbranched β-hydroxyl fatty acid chain that is saturated for all homologs, except for orfamides E and F, which contain a single double bond within the fatty acid chain. Orfamides A and C possess a valine in the fourth position, as opposed to the other orfamides possessing an isoleucine at the fourth position.
Figure 4(A) Swarming motility of wild type strain Pseudomonas sp. CMR5c and deletion mutants in orfamide biosynthesis (CMR5cΔofa) or in orfamide regulatory genes (CMR5cΔluxRup and CMR5cΔLuxRdown). In all mutants swarming was restored by chemical complementation with orfamide B. Representative plates are shown and the diameter of soft agar plates used in this assay is 9 cm. The insert shows the UPLC-MS analysis of wild type and mutant strains. (B) Swarming motility of P. protegens CHA0, P. protegens Pf-5, Pseudomonas sp. CMR5c, Pseudomonas sp. CMR12a, and its sessilin mutant CMR12a-Clp1.
Figure 5Microscopic assays showing the effect of various concentrations of orfamides (Orfamide A, orfamide B, and orfamide G) on hyphal branching of . Sterile microscopic glass slides were covered with a thin, flat layer of water agar (Bacto agar; Difco) and placed in a plastic Petri dish containing moist sterile filter paper. An agar plug (Diameter = 5 mm) taken from an actively growing colony of R. solani was inoculated at the center of each glass slide. Two droplets (15 μl each) containing 0, 10, or 100 μM orfamide were placed at two sides of the glass slide at about 2 cm from the fungal plug. Slides were incubated for 36 h at 28°C before evaluation under an Olympus BX51 microscope.
Figure 6Effect of orfamides (orfamide A, orfamide B, and orfamide G) on the viability of zoospores of the oomycete pathogens . Zoospores of both pathogens were incubated in the presence of increasing concentrations of orfamide A and B and the time (in seconds) that it took to observe lysis was recorded immediately under an Olympus BX51 microscope. Data are the mean of three repetitions. Vertical bars indicate standard deviations. Different letters indicate significant differences among different treatments for that specific concentration (Tukey's test, α = 0.05).
Figure 7(A) Effect of different concentrations (1, 10, and 50 μM) of orfamides (orfamide A, B, and G) on appressorium formation in Magnaporthe oryzae VT5M1. The control treatment (Con) received the same amount of DMSO as the orfamide treatments. Data are shown as mean value (±SD) for three biological repeats. Different letters indicate significant differences among different treatments (Tukey's test; α = 0.05). (B) Representative pictures of appressoria formation in M. oryzae in control (DMSO) and orfamide treatments after 8 h incubation (in vitro assay) or 24 h incubation (in planta assay). S, spore; GT, germ tube; Ap, appressorium. Scale bar is 20 μm.
Figure 8Influence of orfamides (Orfamide A, B, and G) on rice blast symptoms caused by . Spores of M. oryzae were mixed with different concentrations of orfamides and sprayed on rice plants at the five-leaf stage. Disease was assessed 6 days post infection by counting the number of sporulating susceptible-type lesions on the fourth leaf of rice plants and expressed relative to control plants. Biocontrol assays were repeated independently for three times and showed similar results, data from one representative experiment are shown. Different letters indicate significant differences among different treatments (Mann-Whitney: n = 24; α = 0.05). Pictures show representative disease symptoms in the different treatments. Scale bar is 1 cm.